Travere Therapeutics nimmt an vier Investorenkonferenzen teil

• Travere Therapeutics präsentiert am 10. November 2026 um 8:00 Uhr ET auf der Guggenheim Global Healthcare Conference.
• Auftritt bei der Stifel 2026 Healthcare Conference am 11. November 2026 um 15:20 Uhr ET.
• Teilnahme an der UBS Global Biopharma Conference am 16. November 2026 um 11:20 Uhr GMT.
• Präsentation auf der Jefferies London Healthcare Conference am 17. November 2026 um 8:00 Uhr GMT.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Travere Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202611031630BIZWIRE_USPR_____20261103_BW317035) on November 03, 2026, and is solely responsible for the information contained therein.